Bristol-Myers Escapes $3.4B Apotex Suit Over Plavix Deal

Law360, Miami (March 14, 2013, 5:56 PM EDT) -- Bristol-Myers Squibb Co. and partner Sanofi-Aventis SA won a defense verdict Wednesday in a $3.4 billion suit in which generic-drug maker Apotex Inc. alleged the companies breached a patent litigation settlement over blood thinner Plavix by lying to antitrust regulators.

After a nine-day trial in the Seventeenth Judicial Circuit Court of Florida, a jury returned a unanimous verdict for the defendants in the dispute over a 2006 settlement that a consortium of state attorneys general and the U.S. Federal Trade Commission rejected.

“We are gratified by the jury's decision and believe it is correct given the facts of the case,” Bristol-Myers...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!